Toolkit/EL346

EL346

Protein Domain·Research·Since 2014

Also known as: blue light-activated HK from Erythrobacter litoralis HTCC2594

Taxonomy: Mechanism Branch / Component. Workflows sit above the mechanism and technique branches rather than replacing them.

Summary

EL346 is a full-length blue light-activated histidine kinase from Erythrobacter litoralis HTCC2594 that contains a LOV photosensor domain. Structural evidence indicates that the LOV domain regulates kinase state by controlling intramolecular domain interactions, maintaining an inhibited dark-state conformation, and releasing that inhibition upon photoactivation.

Usefulness & Problems

Why this is useful

EL346 is useful as a mechanistically defined model for blue-light regulation of histidine kinase signaling. It provides a structurally characterized example of how a LOV sensor domain can couple light input to kinase control through intramolecular inhibition and dimerization-related regulation.

Problem solved

EL346 helps address the problem of understanding how sensory light input is transduced into histidine kinase output at the level of full-length domain architecture. The reported structure specifically clarifies how dark-state inhibition and light-dependent changes in domain interfaces can regulate kinase activity.

Taxonomy & Function

Primary hierarchy

Mechanism Branch

Component: A low-level protein part used inside a larger architecture that realizes a mechanism.

Techniques

No technique tags yet.

Target processes

signaling

Input: Light

Implementation Constraints

EL346 is a full-length protein from Erythrobacter litoralis HTCC2594 and includes a LOV sensor domain linked to histidine kinase output regions including DHpL and CA domains. The available evidence supports blue-light responsiveness, but the supplied material does not provide construct design details, cofactor requirements, expression conditions, or delivery guidance.

The evidence provided is limited to a single structural study and associated mechanistic interpretation. The supplied record does not describe independent replication, quantitative activity measurements, spectral parameters, or validation across multiple biological contexts.

Validation

Cell-freeBacteriaMammalianMouseHumanTherapeuticIndep. Replication

Supporting Sources

Ranked Claims

Claim 1dark state inhibitionsupports2014Source 1needs review

The DHpL domain contacts the CA domain and keeps EL346 in an inhibited conformation in the dark.

The DHpL domain also contacts the catalytic/ATP-binding (CA) domain, keeping EL346 in an inhibited conformation in the dark.
Claim 2dark state inhibitionsupports2014Source 1needs review

The DHpL domain contacts the CA domain and keeps EL346 in an inhibited conformation in the dark.

The DHpL domain also contacts the catalytic/ATP-binding (CA) domain, keeping EL346 in an inhibited conformation in the dark.
Claim 3dark state inhibitionsupports2014Source 1needs review

The DHpL domain contacts the CA domain and keeps EL346 in an inhibited conformation in the dark.

The DHpL domain also contacts the catalytic/ATP-binding (CA) domain, keeping EL346 in an inhibited conformation in the dark.
Claim 4dark state inhibitionsupports2014Source 1needs review

The DHpL domain contacts the CA domain and keeps EL346 in an inhibited conformation in the dark.

The DHpL domain also contacts the catalytic/ATP-binding (CA) domain, keeping EL346 in an inhibited conformation in the dark.
Claim 5dark state inhibitionsupports2014Source 1needs review

The DHpL domain contacts the CA domain and keeps EL346 in an inhibited conformation in the dark.

The DHpL domain also contacts the catalytic/ATP-binding (CA) domain, keeping EL346 in an inhibited conformation in the dark.
Claim 6dark state inhibitionsupports2014Source 1needs review

The DHpL domain contacts the CA domain and keeps EL346 in an inhibited conformation in the dark.

The DHpL domain also contacts the catalytic/ATP-binding (CA) domain, keeping EL346 in an inhibited conformation in the dark.
Claim 7dark state inhibitionsupports2014Source 1needs review

The DHpL domain contacts the CA domain and keeps EL346 in an inhibited conformation in the dark.

The DHpL domain also contacts the catalytic/ATP-binding (CA) domain, keeping EL346 in an inhibited conformation in the dark.
Claim 8mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 9mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 10mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 11mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 12mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 13mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 14mechanism of regulationsupports2014Source 1needs review

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.
Claim 15mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 16mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 17mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 18mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 19mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 20mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 21mechanistic modelsupports2014Source 1needs review

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.
Claim 22photoactivation mechanismsupports2014Source 1needs review

Light stimulation weakens interdomain interactions to facilitate EL346 activation.

Upon light stimulation, interdomain interactions weaken to facilitate activation.
Claim 23photoactivation mechanismsupports2014Source 1needs review

Light stimulation weakens interdomain interactions to facilitate EL346 activation.

Upon light stimulation, interdomain interactions weaken to facilitate activation.
Claim 24photoactivation mechanismsupports2014Source 1needs review

Light stimulation weakens interdomain interactions to facilitate EL346 activation.

Upon light stimulation, interdomain interactions weaken to facilitate activation.
Claim 25photoactivation mechanismsupports2014Source 1needs review

Light stimulation weakens interdomain interactions to facilitate EL346 activation.

Upon light stimulation, interdomain interactions weaken to facilitate activation.
Claim 26photoactivation mechanismsupports2014Source 1needs review

Light stimulation weakens interdomain interactions to facilitate EL346 activation.

Upon light stimulation, interdomain interactions weaken to facilitate activation.
Claim 27photoactivation mechanismsupports2014Source 1needs review

Light stimulation weakens interdomain interactions to facilitate EL346 activation.

Upon light stimulation, interdomain interactions weaken to facilitate activation.
Claim 28photoactivation mechanismsupports2014Source 1needs review

Light stimulation weakens interdomain interactions to facilitate EL346 activation.

Upon light stimulation, interdomain interactions weaken to facilitate activation.
Claim 29structural statesupports2014Source 1needs review

EL346 functions as a monomer rather than as a dimeric histidine kinase.

Contrary to the standard view that signaling occurs within HK dimers, EL346 functions as a monomer.
Claim 30structural statesupports2014Source 1needs review

EL346 functions as a monomer rather than as a dimeric histidine kinase.

Contrary to the standard view that signaling occurs within HK dimers, EL346 functions as a monomer.
Claim 31structural statesupports2014Source 1needs review

EL346 functions as a monomer rather than as a dimeric histidine kinase.

Contrary to the standard view that signaling occurs within HK dimers, EL346 functions as a monomer.
Claim 32structural statesupports2014Source 1needs review

EL346 functions as a monomer rather than as a dimeric histidine kinase.

Contrary to the standard view that signaling occurs within HK dimers, EL346 functions as a monomer.
Claim 33structural statesupports2014Source 1needs review

EL346 functions as a monomer rather than as a dimeric histidine kinase.

Contrary to the standard view that signaling occurs within HK dimers, EL346 functions as a monomer.
Claim 34structural statesupports2014Source 1needs review

EL346 functions as a monomer rather than as a dimeric histidine kinase.

Contrary to the standard view that signaling occurs within HK dimers, EL346 functions as a monomer.
Claim 35structural statesupports2014Source 1needs review

EL346 functions as a monomer rather than as a dimeric histidine kinase.

Contrary to the standard view that signaling occurs within HK dimers, EL346 functions as a monomer.

Approval Evidence

1 source5 linked approval claimsfirst-pass slug el346
Here, we report the full-length structure of a blue light-activated HK from Erythrobacter litoralis HTCC2594 (EL346)

Source:

dark state inhibitionsupports

The DHpL domain contacts the CA domain and keeps EL346 in an inhibited conformation in the dark.

The DHpL domain also contacts the catalytic/ATP-binding (CA) domain, keeping EL346 in an inhibited conformation in the dark.

Source:

mechanism of regulationsupports

The LOV sensor domain controls kinase activity and prevents dimerization by binding one side of the DHpL domain.

Its structure reveals that the light-oxygen-voltage (LOV) sensor domain both controls kinase activity and prevents dimerization by binding one side of a dimerization/histidine phosphotransfer-like (DHpL) domain.

Source:

mechanistic modelsupports

The LOV domain controls kinase activity by affecting stability of the DHpL/CA interface and releasing the CA domain from an inhibited conformation upon photoactivation.

Our data suggest that the LOV domain controls kinase activity by affecting the stability of the DHpL/CA interface, releasing the CA domain from an inhibited conformation upon photoactivation.

Source:

photoactivation mechanismsupports

Light stimulation weakens interdomain interactions to facilitate EL346 activation.

Upon light stimulation, interdomain interactions weaken to facilitate activation.

Source:

structural statesupports

EL346 functions as a monomer rather than as a dimeric histidine kinase.

Contrary to the standard view that signaling occurs within HK dimers, EL346 functions as a monomer.

Source:

Comparisons

Source-backed strengths

A key strength is the availability of full-length structural evidence for the intact blue light-activated histidine kinase. The cited study supports a specific mechanistic model in which the LOV domain binds one side of the DHpL domain, affects the DHpL/CA interface, prevents dimerization, and relieves CA-domain inhibition upon photoactivation.

Ranked Citations

  1. 1.
    StructuralSource 1Proceedings of the National Academy of Sciences2014Claim 1Claim 2Claim 3

    Extracted from this source document.